Bio-Rad Labs (BIO) Issues Q3 EPS of $1.61, Beats by 8c
Get Alerts BIO Hot Sheet
Price: $285.94 -2.22%
Revenue Growth %: -4.3%
Financial Fact:
Gross profit: 280.23M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: -4.3%
Financial Fact:
Gross profit: 280.23M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q3 EPS of $1.61, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $516.5 million versus the consensus estimate of $511.47 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
- Hooker Furniture (HOFT) Tops Q1 EPS by 14c
- Vera Bradley (VRA) Misses Q1 EPS by 26c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share